» Articles » PMID: 26858869

Use of Mesenchymal Stem Cell-Conditioned Medium to Activate Islets in Preservation Solution

Overview
Journal Cell Med
Publisher Sage Publications
Date 2016 Feb 10
PMID 26858869
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic islet transplantation has received widespread attention as a promising treatment for type 1 diabetes. However, islets for transplantation are subject to damage from a number of sources, including ischemic injury during removal and delivery of the donor pancreas, enzymatic digestion during islet isolation, and reperfusion injury after transplantation in the recipient. Here we found that protein fractions secreted by mesenchymal stem cells (MSCs) were capable of activating preserved islets. A conditioned medium from the supernatant obtained by culturing adipose tissue MSCs (derived from wild-type Lewis rats) was prepared for 2 days in serum-free medium. Luc-Tg rat islets to which an organ preservation solution was added were then incubated at 4°C with fractions of various molecular weights prepared from the conditioned medium. Under the treatment with some of the fractions, by 4 days the relative luminescence intensities (representative of the ATP levels of the cold-preserved islets) had increased to over 150% of their initial values. Our novel system may be able to restore isolated islets to the condition they were in before transport, culture, and transplantation.

Citing Articles

Improved Preservation of Rat Small Intestine Transplantation Graft by Introduction of Mesenchymal Stem Cell-Secreted Fractions.

Teratani T, Fujimoto Y, Sakuma Y, Kasahara N, Maeda M, Miki A Transpl Int. 2024; 37:11336.

PMID: 38962471 PMC: 11219629. DOI: 10.3389/ti.2024.11336.


Proposal of Simplified Standardization of the Cell-Growth-Promoting Activity of Human Adipose Tissue Mesenchymal Stromal Cell Culture Supernatants.

Enosawa S, Kobayashi S, Kobayashi E Int J Mol Sci. 2024; 25(10).

PMID: 38791236 PMC: 11121723. DOI: 10.3390/ijms25105197.


Toward transplantation tolerance with adipose tissue-derived therapeutics.

Cheng H, Anggelia M, Lin C, Wei F Front Immunol. 2023; 14:1111813.

PMID: 37187733 PMC: 10175575. DOI: 10.3389/fimmu.2023.1111813.


Role of Mesenchymal Stem/Stromal Cells in Modulating Ischemia/Reperfusion Injury: Current State of the Art and Future Perspectives.

Miceli V, Bulati M, Gallo A, Iannolo G, Busa R, Conaldi P Biomedicines. 2023; 11(3).

PMID: 36979668 PMC: 10045387. DOI: 10.3390/biomedicines11030689.


Mesenchymal Stem Cells Secretions Enhanced ATP Generation on Isolated Islets during Transplantation.

Teratani T, Kasahara N, Fujimoto Y, Sakuma Y, Miki A, Goto M Islets. 2022; 14(1):69-81.

PMID: 35034568 PMC: 8765074. DOI: 10.1080/19382014.2021.2022423.


References
1.
Pittenger M, Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J . Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284(5411):143-7. DOI: 10.1126/science.284.5411.143. View

2.
Soria B, Roche E, Berna G, Leon-Quinto T, Reig J, Martin F . Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes. 2000; 49(2):157-62. DOI: 10.2337/diabetes.49.2.157. View

3.
Shapiro A, Lakey J, Ryan E, Korbutt G, Toth E, Warnock G . Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000; 343(4):230-8. DOI: 10.1056/NEJM200007273430401. View

4.
Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R . Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science. 2001; 292(5520):1389-94. DOI: 10.1126/science.1058866. View

5.
Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki K, Tzukerman M . Insulin production by human embryonic stem cells. Diabetes. 2001; 50(8):1691-7. DOI: 10.2337/diabetes.50.8.1691. View